The ACCJ Journal
Rob Claar, CEO and founder of healthcare investment, development, and commercialization platform HekaBio joins us to discuss how overseas healthcare companies can gain regulatory approval in Japan and put their innovations in the hands of Japanese doctors and patients.
18 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The ACCJ Journal!